VYOME HOLDINGS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VYOME HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $30.00K.
- VYOME HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2021-12-31 was $0.00.
- VYOME HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2021-09-30 was $130.00K.
- VYOME HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2020-12-31 was $0.00.
- VYOME HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2025 was $100.00K.
- VYOME HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2021 was $130.00K, a 36.59% decline from fiscal 2020.
- VYOME HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2020 was $205.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $30.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $100.00K 10-K · filed 2026-03-18 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $130.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $130.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $205.00K 10-K · filed 2022-04-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | |
| 2020-06-30 | $205.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |